(Q33952995)

English

Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

0 references

anti-retroviral agent

0 references

19

object named as

Fauci AS

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1

object named as

Dybul M

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Chun TW

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Yoder C

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Hidalgo B

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Belson M

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Hertogs K

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Larder B

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dewar RL

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Fox CH

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Hallahan CW

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Justement JS

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Migueles SA

12

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Metcalf JA

13

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Davey RT

14

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Daucher M

15

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Pandya P

16

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Baseler M

17

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Ward DJ

18

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

4 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

98

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

15161-15166

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Prevalence and predictive value of intermittent viremia with combination hiv therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=65000

5 July 2018

Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=65000

5 July 2018

Antiretroviral resistance during successful therapy of HIV type 1 infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=65000

5 July 2018

Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=65000

5 July 2018

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=65000

5 July 2018

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=65000

5 July 2018

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=65000

5 July 2018

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=65000

5 July 2018

A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=65000

5 July 2018

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=65000

5 July 2018

Crystalluria and urinary tract abnormalities associated with indinavir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=65000

5 July 2018

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=65000

5 July 2018

HIV-1 replication in patients with undetectable plasma virus receiving HAART. Highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.261568398

21 January 2018

Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.261568398

21 January 2018

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.261568398

21 January 2018

Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidémiologie Clinique du Syndrome d'Immunodéficience Acquise en Aquitaine

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.261568398

21 January 2018

Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.261568398

21 January 2018

Evaluation of lymph node virus burden in human immunodeficiency virus-infected patients receiving efavirenz-based protease inhibitor--sparing highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.261568398

21 January 2018

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.261568398

21 January 2018

Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.261568398

21 January 2018

Quantitative detection of HIV-1 drug resistance mutations by automated DNA sequencing.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.261568398

21 January 2018

Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.261568398

21 January 2018

Residual human immunodeficiency virus type 1 RNA in lymphoid tissue of patients with sustained plasma RNA of <200 copies/mL.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.261568398

21 January 2018

Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.261568398

21 January 2018

Immune control of HIV-1 after early treatment of acute infection

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.261568398

21 January 2018

Studies of body composition and fat distribution in HIV-infected and control subjects

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.261568398

21 January 2018

Visceral abdominal-fat accumulation associated with use of indinavir

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.261568398

21 January 2018

Clinical features and risk factors of lactic acidosis following long-term antiretroviral therapy: 4 fatal cases

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.261568398

21 January 2018

Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.261568398

21 January 2018

AIDS researchers target poor adherence

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.261568398

21 January 2018

PUBLIC HEALTH: HIV/AIDS Treatment for Millions

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.261568398

21 January 2018

HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.261568398

21 January 2018

Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.261568398

21 January 2018

CD40 ligand trimer and IL-12 enhance peripheral blood mononuclear cells and CD4+ T cell proliferation and production of IFN-gamma in response to p24 antigen in HIV-infected individuals: potential contribution of anergy to HIV-specific unresponsivene

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.261568398

21 January 2018

Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11734634

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.261568398

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2001PNAS...9815161D

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33952995&oldid=1945261191"